TOMPKINS MARK N. enters LOMOND THERAPEUTICS HOLDINGS, INC. with 4.75M shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 2/10/2022ACC: 0001213900-22-006621
Director10% Owner
Since Feb 2022
4.75M
Baseline shares
100% direct
4.75M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned4.75M
Total
4.75M direct4.75M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.75M | Direct |
| Total | 4.75M | 4.75M direct |
Derivative Holdings0
No derivative holdings reported